vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.

TRANSCONTINENTAL REALTY INVESTORS INC is the larger business by last-quarter revenue ($12.1M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -234.3%, a 303.1% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 2.3%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 0.7%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.

FHTX vs TCI — Head-to-Head

Bigger by revenue
TCI
TCI
1.3× larger
TCI
$12.1M
$9.2M
FHTX
Growing faster (revenue YoY)
FHTX
FHTX
+221.5% gap
FHTX
223.8%
2.3%
TCI
Higher net margin
TCI
TCI
303.1% more per $
TCI
68.8%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
0.7%
TCI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FHTX
FHTX
TCI
TCI
Revenue
$9.2M
$12.1M
Net Profit
$-21.7M
$8.3M
Gross Margin
Operating Margin
-258.2%
-28.9%
Net Margin
-234.3%
68.8%
Revenue YoY
223.8%
2.3%
Net Profit YoY
-11.1%
7577.8%
EPS (diluted)
$-0.35
$0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
TCI
TCI
Q4 25
$9.2M
$12.1M
Q3 25
$8.2M
$12.8M
Q2 25
$7.6M
$12.2M
Q1 25
$6.0M
$12.0M
Q4 24
$2.9M
$11.8M
Q3 24
$7.8M
$11.6M
Q2 24
$6.9M
$11.8M
Q1 24
$5.0M
$11.9M
Net Profit
FHTX
FHTX
TCI
TCI
Q4 25
$-21.7M
$8.3M
Q3 25
$-15.8M
$724.0K
Q2 25
$-17.9M
$169.0K
Q1 25
$-18.8M
$4.6M
Q4 24
$-19.5M
$108.0K
Q3 24
$-19.1M
$1.7M
Q2 24
$-23.0M
$1.5M
Q1 24
$-25.0M
$2.5M
Operating Margin
FHTX
FHTX
TCI
TCI
Q4 25
-258.2%
-28.9%
Q3 25
-226.9%
-10.9%
Q2 25
-279.2%
-6.8%
Q1 25
-385.0%
-5.3%
Q4 24
-840.5%
-14.3%
Q3 24
-305.5%
-14.4%
Q2 24
-386.6%
-9.2%
Q1 24
-558.3%
-11.2%
Net Margin
FHTX
FHTX
TCI
TCI
Q4 25
-234.3%
68.8%
Q3 25
-194.4%
5.6%
Q2 25
-237.3%
1.4%
Q1 25
-316.4%
38.5%
Q4 24
-682.9%
0.9%
Q3 24
-244.9%
14.7%
Q2 24
-333.6%
12.7%
Q1 24
-495.4%
21.4%
EPS (diluted)
FHTX
FHTX
TCI
TCI
Q4 25
$-0.35
$0.97
Q3 25
$-0.25
$0.08
Q2 25
$-0.28
$0.02
Q1 25
$-0.30
$0.53
Q4 24
$-0.23
$0.01
Q3 24
$-0.31
$0.20
Q2 24
$-0.45
$0.17
Q1 24
$-0.59
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
TCI
TCI
Cash + ST InvestmentsLiquidity on hand
$80.9M
$89.0M
Total DebtLower is stronger
$210.8M
Stockholders' EquityBook value
$-108.5M
$846.7M
Total Assets
$198.1M
$1.1B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
TCI
TCI
Q4 25
$80.9M
$89.0M
Q3 25
$89.3M
$82.7M
Q2 25
$72.6M
$73.5M
Q1 25
$61.0M
$88.6M
Q4 24
$55.5M
$99.7M
Q3 24
$57.7M
$131.6M
Q2 24
$138.9M
$127.5M
Q1 24
$79.3M
$130.8M
Total Debt
FHTX
FHTX
TCI
TCI
Q4 25
$210.8M
Q3 25
$223.5M
Q2 25
$212.4M
Q1 25
$198.2M
Q4 24
$181.9M
Q3 24
$180.3M
Q2 24
$177.4M
Q1 24
$178.3M
Stockholders' Equity
FHTX
FHTX
TCI
TCI
Q4 25
$-108.5M
$846.7M
Q3 25
$-89.7M
$838.4M
Q2 25
$-76.7M
$837.7M
Q1 25
$-61.7M
$837.3M
Q4 24
$-45.5M
$832.3M
Q3 24
$-28.3M
$832.2M
Q2 24
$-14.3M
$830.4M
Q1 24
$-97.5M
$828.9M
Total Assets
FHTX
FHTX
TCI
TCI
Q4 25
$198.1M
$1.1B
Q3 25
$205.0M
$1.1B
Q2 25
$226.2M
$1.1B
Q1 25
$258.7M
$1.1B
Q4 24
$284.0M
$1.1B
Q3 24
$308.4M
$1.1B
Q2 24
$328.6M
$1.0B
Q1 24
$255.0M
$1.0B
Debt / Equity
FHTX
FHTX
TCI
TCI
Q4 25
0.25×
Q3 25
0.27×
Q2 25
0.25×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.22×
Q2 24
0.21×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
TCI
TCI
Operating Cash FlowLast quarter
$-22.3M
$-2.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
TCI
TCI
Q4 25
$-22.3M
$-2.9M
Q3 25
$-18.9M
$8.2M
Q2 25
$-21.0M
$-2.9M
Q1 25
$-24.0M
$-7.4M
Q4 24
$-24.5M
$1.3M
Q3 24
$-21.0M
$13.7M
Q2 24
$-25.5M
$-511.0K
Q1 24
$-29.3M
$3.9M
Free Cash Flow
FHTX
FHTX
TCI
TCI
Q4 25
Q3 25
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
FCF Margin
FHTX
FHTX
TCI
TCI
Q4 25
Q3 25
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
Capex Intensity
FHTX
FHTX
TCI
TCI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
Q3 24
4.0%
Q2 24
0.2%
Q1 24
2.0%
Cash Conversion
FHTX
FHTX
TCI
TCI
Q4 25
-0.35×
Q3 25
11.28×
Q2 25
-17.24×
Q1 25
-1.61×
Q4 24
12.13×
Q3 24
8.03×
Q2 24
-0.34×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons